TRANSLATING ADVANCES IN CELL-FREE FETAL NUCLEIC ACIDS INTO BETTER PERINATAL CARE

Grant number: 1105603 | Funding period: 2016 - 2019

Completed

Abstract

My overall aim is to translate advances in biotechnology into better care for pregnant women. My first aim is to study brain development by analyzing the fluid that surrounds the unborn baby. This work may provide more information to women about their baby’s expected outcome. My second aim is to evaluate the impact of new DNA technologies on the detection of genetic conditions in the baby before birth. This work will confirm if this new generation of tests is fulfilling our high expectations.

Related publications (15)

Scholarly works icon

Noninvasive Prenatal Testing for Chromosomal and Genetic Conditions

Lisa Hui

Scholarly works icon

Seminars in Fetal and Neonatal Medicine

2019-01-01

Scholarly works icon

Prenatal diagnosis for single‐gene disorders in Victoria, Australia, 1977‐201

Alice Poulton, Jane Halliday, Sharon Lewis, David Amor, Lisa Hui

2018-01-01

Scholarly works icon

The evolution of ultrasound-indicated prenatal diagnosis over the past two decades: a state-wide retrospective cohort study from 1994-2016

Emily Lostchuck, Alice Poulton, Jane Halliday, Lisa Hui

2018-01-01

Scholarly works icon

OC15.02: Evolving role of ultrasound in the NIPT era: population-based trends in screening and diagnostic testing for fetal aneuploidy

L Hui, B Hutchinson, A Poulton, J Halliday

2017-09-01

Scholarly works icon

Poster Abstracts of the ISPD 21st International Conference on Prenatal Diagnosis and Therapy, San Diego, California, USA, 9-12 July 2017

2017-07-01

Scholarly works icon

Declining invasive prenatal diagnostic procedures: A comparison of tertiary hospital and national data from 2012 to 2015

Kristine Johnson, Joanne Kelley, Virginia Saxton, Susan P Walker, Lisa Hui

2017-04-01

Scholarly works icon

Noninvasive Prenatal DNA Testing: The Vanguard of Genomic Medicine

Lisa Hui, Diana W Bianchi

2017-01-01

Scholarly works icon

Population‐based trends in the prenatal diagnosis of sexchromosome aneuploidies in the pre‐and post‐NIPT era

Allanah Howard-Bath, Alice Poulton, Jane Halliday, Lisa Hui

2017-01-01

Scholarly works icon

Socioeconomic status and clinical variation in prenatal testing in the NIPT era

Lisa Hui, Jenna Barclay, Alice Poulton, Briohny Hutchinson, Jane Halliday

2017-01-01

Scholarly works icon

Noninvasive prenatal testing for aneuploidy using cell-free DNA - New implications for maternal health

Lisa Hui

2016-12-01

Scholarly works icon

Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening

Paul A Cohen, Nicola Flowers, Stephen Tong, Natalie Hannan, Mark D Pertile, Lisa Hui

2016-08-24

Scholarly works icon

Cell-free DNA testing for 22q11.2 deletion syndrome: appraising the viability, effectiveness and appropriateness of screening

L Hui

2016-02-01

Scholarly works icon

How to safeguard competency and training in invasive prenatal diagnosis: 'the elephant in the room'

L Hui, A Tabor, SP Walker, MD Kilby

2016-01-01

Scholarly works icon

Population-based trends in prenatal screening and diagnosis for aneuploidy: a retrospective analysis of 38years of state-wide data

L Hui, EE Muggli, JL Halliday

2016-01-01

Researchers